About me
Thomas is the CEO and Co-Founder of Owkin, leading medical research and business intelligence. He is a former Assistant Professor of Clinical Onco-Hematology at Hopital Henri Mondor in Paris and a former member of Ari Melnick’s lab at Weill Cornell Medical College, where he co-led several projects focused on predicting resistance to chemotherapy in B-cell lymphoma. He ensures that patient health is prioritized when developing breakthrough medical technologies, bringing a patient-centric approach to each Owkin project.
